Related Experiment Video
Updated: May 9, 2026
11:53
Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics
Jonathan O Martinez1, Ciro Chiappini, Arturas Ziemys
1Department of Nanomedicine, The Methodist Hospital Research Institute, 6670 Bertner Ave., Houston, TX 77030, USA.
Biomaterials
|August 6, 2013
Summary
This study reveals how nanovector pore size affects drug delivery. Larger pores enhance nanoparticle loading and degradation but slow down drug release, optimizing therapeutic targeting.
Area of Science:
- Biomedical Engineering
- Materials Science
- Drug Delivery Systems
Background:
- Nanovectors offer targeted drug delivery to minimize off-target effects and improve therapeutic index.
- Understanding nanovector degradation and release kinetics is crucial for effective therapeutic applications.
Purpose of the Study:
- To investigate the relationship between nanovector pore size and its impact on degradation, nanoparticle loading, and release dynamics.
- To elucidate how pore size influences the controlled release of therapeutic payloads.
Main Methods:
- Characterization of nanovector degradation through multi-step progression analysis.
- Empirical studies on nanoparticle loading and release kinetics.
- Diffusion modeling to understand release modulation by pore size.
Main Results:
- Larger pore sizes correlated with faster nanovector degradation and higher nanoparticle loading.
- Nanovectors with larger pores exhibited slower release rates.
- Degradation involved initial size reduction and subsequent pore enlargement, isolating the core.
Conclusions:
- Nanovector pore size is a critical determinant of degradation, loading capacity, and release kinetics.
- Controlled release is modulated by pore size-dependent penetration into the nanovector's porous core.
- Tailoring pore size offers a strategy for optimizing nanovector-based drug delivery systems.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...